BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19622837)

  • 21. The assembly and secretion of apolipoprotein B-48-containing very low density lipoproteins in McA-RH7777 cells.
    Stillemark P; Borén J; Andersson M; Larsson T; Rustaeus S; Karlsson KA; Olofsson SO
    J Biol Chem; 2000 Apr; 275(14):10506-13. PubMed ID: 10744742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.
    Bamji-Mirza M; Sundaram M; Zhong S; Yao EF; Parks RJ; Yao Z
    J Lipid Res; 2011 Mar; 52(3):540-8. PubMed ID: 21189265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.
    Fisher EA; Khanna NA; McLeod RS
    J Lipid Res; 2011 Jun; 52(6):1170-1180. PubMed ID: 21421992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment.
    McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z
    J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
    Lindén D; Lindberg K; Oscarsson J; Claesson C; Asp L; Li L; Gustafsson M; Borén J; Olofsson SO
    J Biol Chem; 2002 Jun; 277(25):23044-53. PubMed ID: 11925428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only mice.
    Conde-Knape K; Okada K; Ramakrishnan R; Shachter NS
    J Lipid Res; 2004 Dec; 45(12):2235-44. PubMed ID: 15342689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease.
    Silbernagel G; Scharnagl H; Kleber ME; Hoffmann MM; Delgado G; Stojakovic T; Gary T; Zeng L; Ritsch A; Zewinger S; Speer T; Schunkert H; Landmesser U; März W; Grammer TB
    Atherosclerosis; 2020 Oct; 311():84-90. PubMed ID: 32949947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monosialyl Ganglioside GM3 Decreases Apolipoprotein B-100 Secretion in Liver Cells.
    Choi H; Jin UH; Kang SK; Abekura F; Park JY; Kwon KM; Suh SJ; Cho SH; Ha KT; Lee YC; Chung TW; Kim CH
    J Cell Biochem; 2017 Aug; 118(8):2168-2181. PubMed ID: 28019668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.
    Jia H; Li X; Liu G; Loor JJ; Bucktrout R; Sun X; Li G; Shu X; Dong J; Wang Y; Zuo R; Wang Z; Li X
    J Dairy Sci; 2019 Jan; 102(1):833-845. PubMed ID: 30415861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C; Khoo C; Ikewaki K; Sacks FM
    J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of endurance training upon lipid metabolism in the liver of cachectic tumour-bearing rats.
    Lira FS; Tavares FL; Yamashita AS; Koyama CH; Alves MJ; Caperuto EC; Batista ML; Seelaender M
    Cell Biochem Funct; 2008 Aug; 26(6):701-8. PubMed ID: 18636434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase.
    Casaschi A; Wang Q; Dang K; Richards A; Theriault A
    Lipids; 2002 Jul; 37(7):647-52. PubMed ID: 12216835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells.
    Elzinga BM; Baller JF; Mensenkamp AR; Yao Z; Agellon LB; Kuipers F; Verkade HJ
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):93-103. PubMed ID: 14729072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis.
    Pan M; Liang Js JS; Fisher EA; Ginsberg HN
    J Biol Chem; 2002 Feb; 277(6):4413-21. PubMed ID: 11704664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assembly of very low density lipoproteins in rat hepatoma McA-RH7777 cells is inhibited by phospholipase A2 antagonists.
    Tran K; Wang Y; DeLong CJ; Cui Z; Yao Z
    J Biol Chem; 2000 Aug; 275(32):25023-30. PubMed ID: 10827200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.